How many institutions held AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in Q1 2018?

63 institutional investors reported AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value for Q1 2018. Use the holders table for investor-level position and value details.

Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Q: What does CUSIP 05156V102 represent in this 13F holders report?

CUSIP 05156V102 is the security identifier for AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 05156V102

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 132,929,348
Total 13F shares: 21,720,891
Share change: -2,138,984
Total reported value: $112,732,308
Put/Call ratio: 469%
Price per share: $5.19
Number of holders: 63
Value change: -$10,024,771
Number of buys: 27
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 05156V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	3.6%	4,808,483	$21,782,000	—	31 Dec 2017	13F
FMR LLC	13F	Company	3.6%	4,804,481	$21,764,000	—	31 Dec 2017	13F
Polar Capital LLP	13F	Company	1.7%	2,300,000	$10,419,000	—	31 Dec 2017	13F
ORBIMED ADVISORS LLC	13F	Company	1.4%	1,797,400	$8,142,000	—	31 Dec 2017	13F
FRANKLIN RESOURCES INC	13F	Company	1.3%	1,664,400	$7,540,000	—	31 Dec 2017	13F
Vivo Capital, LLC	13F	Company	0.91%	1,213,290	$5,496,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.9%	1,194,550	$5,411,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	0.54%	719,713	$3,261,000	—	31 Dec 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.44%	581,517	$2,634,000	—	31 Dec 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.4%	537,000	$2,433,000	—	31 Dec 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.38%	500,000	$2,265,000	—	31 Dec 2017	13F
Hudson Bay Capital Management LP	13F	Company	0.34%	450,000	$2,039,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.28%	368,189	$1,668,000	—	31 Dec 2017	13F
AWM Investment Company, Inc.	13F	Company	0.27%	354,520	$1,606,000	—	31 Dec 2017	13F
Abingworth LLP	13F	Company	0.19%	252,129	$1,142,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.18%	237,353	$1,075,000	—	31 Dec 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.17%	227,265	$1,030,000	—	31 Dec 2017	13F
IRONWOOD INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	185,865	$842,000	—	31 Dec 2017	13F
Kazazian Asset Management, LLC	13F	Company	0.12%	156,126	$707,000	—	31 Dec 2017	13F
Creative Planning	13F	Company	0.11%	150,200	$683,000	—	31 Dec 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.11%	140,360	$636,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	127,289	$577,000	—	31 Dec 2017	13F
UBS Group AG	13F	Company	0.09%	118,835	$538,000	—	31 Dec 2017	13F
S.c.a. Candriam	13F	Individual	0.09%	118,000	$535,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.07%	92,400	$421,000	—	31 Dec 2017	13F
BANK OF MONTREAL /CAN/	13F	Company	0.07%	92,460	$419,000	—	31 Dec 2017	13F
A.R.T. Advisors, LLC	13F	Company	0.05%	66,365	$300,000	—	31 Dec 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.04%	53,001	$242,000	—	31 Dec 2017	13F
Cutler Capital Management, LLC	13F	Company	0.04%	50,000	$226,000	—	31 Dec 2017	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.04%	48,400	$219,000	—	31 Dec 2017	13F
Spark Investment Management LLC	13F	Company	0.03%	33,700	$153,000	—	31 Dec 2017	13F
ProShare Advisors LLC	13F	Company	0.02%	28,783	$130,000	—	31 Dec 2017	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.02%	26,500	$120,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	24,941	$112,000	—	31 Dec 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	24,303	$110,000	—	31 Dec 2017	13F
STATE OF MICHIGAN RETIREMENT SYSTEM	13F	Company	0.02%	22,500	$102,000	—	31 Dec 2017	13F
Dynamic Technology Lab Private Ltd	13F	Company	0.02%	21,093	$96,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	19,595	$89,000	—	31 Dec 2017	13F
INFRASTRUCTURE CAPITAL ADVISORS, LLC	13F	Company	0.01%	19,303	$87,000	—	31 Dec 2017	13F
CREDIT SUISSE AG/	13F	Company	0.01%	19,279	$87,000	—	31 Dec 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	17,107	$77,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	0.01%	14,771	$67,000	—	31 Dec 2017	13F
Noven Financial Group, Inc.	13F	Company	0.01%	14,650	$66,000	—	31 Dec 2017	13F
Patriot Financial Group Insurance Agency, LLC	13F	Company	0.01%	11,100	$57,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.01%	11,657	$52,000	—	31 Dec 2017	13F
MGO ONE SEVEN LLC	13F	Company	0.01%	11,000	$50,000	—	31 Dec 2017	13F
STIFEL FINANCIAL CORP	13F	Company	0.01%	10,946	$49,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	0.01%	10,578	$48,000	—	31 Dec 2017	13F
LEVIN CAPITAL STRATEGIES, L.P.	13F	Company	0.01%	10,000	$45,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	9,478	$42,000	—	31 Dec 2017	13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2018

As of 31 Mar 2018, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,720,891 shares. The largest 10 holders included NEA Management Company, LLC, FMR LLC, Polar Capital LLP, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Vivo Capital, LLC, BlackRock Inc., ORBIMED ADVISORS LLC, MORGAN STANLEY, and Alyeska Investment Group, L.P.. This page lists 63 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

Q1 2018 holders

Holder diff

-3

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.